Advertisement

Small-fiber neuropathy definition, diagnosis, and treatment

  • Natalia Y. Basantsova
  • Anna A. StarshinovaEmail author
  • Amir Dori
  • Yulia S. Zinchenko
  • Piotr K. Yablonskiy
  • Yehuda Shoenfeld
Review Article
  • 91 Downloads

Abstract

In the last 30 years, improvement of diagnostic methods enabled routine evaluation of small A-delta and C nerve fibers impairment, which results with the clinical condition known as a small-fiber neuropathy (SFN). This syndrome develops as a result of metabolic, toxic, immune-mediated, or genetic factors. The main clinical features include neuropathic pain and autonomic disturbance, which are occasionally disclaimed due to outstanding fatigue, daily performance decline, anxiety, and depression. As clinical, neurological, nerve conduction, and electromyography studies are commonly normal, diagnosis often depends on the finding of decreased intra-epidermal density of nerve fibers, per skin biopsy. This review highlights the etiology, clinical, diagnostic aspects, and SFN treatment.

Keywords

Small-fiber neuropathy Neuropathic pain Autoimmune diseases Sarcoidosis 

Notes

Source of funding

This work is supported by the grant of the Government of the Russian Federation for the state support of scientific research carried out under the supervision of leading scientists, agreement 14.W03.31.0009, on the basis of SPbU projects of 13.02. 2017.

References

  1. 1.
    Lauria G, Merkies ISG, Faber CG (2012) Small fiber neuropathy. Curr Opin Neurobiol 25:542–549CrossRefGoogle Scholar
  2. 2.
    Brouwer BA, Bakkers M, Hoeijmakers JGJ, Faber CG, Merkies ISJ (2015) Improving assessment in small fiber neuropathy. J Peripher Nerv Syst 20:333–340CrossRefGoogle Scholar
  3. 3.
    Sene D (2018) Small fiber neuropathy: diagnosis, causes and treatment. Joint Bone Spine 85(5):553–559CrossRefGoogle Scholar
  4. 4.
    Voortman M, Fritz D, Vogels OJM, Eftimov F, van de Beek D, Brouwer MC, Drent M (2017) Small fiber neuropathy: a disabling and underrecognized syndrome. Curr Opin Pulm Med 23(5):447–457CrossRefGoogle Scholar
  5. 5.
    Zeng L, Alongkronrusmee D, van Rijet RM (2017) An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US. J Pain Res 10:219–222CrossRefGoogle Scholar
  6. 6.
    Tierney EF, Thurman DJ, Becles JL et al (2013) Association of statin use with peripheral neuropathy in the US population 40 years or older. J Diabetes 5:207–215CrossRefGoogle Scholar
  7. 7.
    Terkelsen AJ, Karlsson P, Lauria G, Freeman R, Finnerup NB, Jensen TS (2017) The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. Lancet Neurol 16:934–944CrossRefGoogle Scholar
  8. 8.
    Birnbaum J, Lalji A, Saed A et al (2018) Biopsy-proven small-Fiber neuropathy in primary Sjögren’s syndrome: neuropathic pain characteristics, autoantibody findings, and histopathological features. Arthritis Care Res.  https://doi.org/10.1002/acr.23762
  9. 9.
    Barrett SL, Dellon AL (2016) Small fiber neuropathy. Differential diagnosis and clinical implication. Clin Podiatr Med Surg 33:185–118CrossRefGoogle Scholar
  10. 10.
    Zivkovic SA, Lacomis D, Giuliani MJ (2001) Sensory neuropathy associated with metronidazole: report of four cases and review of the literature. J Clin Neuromuscul Dis 3(1):8–12CrossRefGoogle Scholar
  11. 11.
    Tan IL, Ebenezer GJ, Hauer P et al (2012) Peripheral nerve toxic effects of nitrofurantoin. Arch Neurol 69(2):265–268CrossRefGoogle Scholar
  12. 12.
    Chao CC, Sun HY, Chang YC (2008) Painful neuropathy with skin denervation after prolonged use of linezolid. J Neurol Neurosurg Psychiatry 79:97–99CrossRefGoogle Scholar
  13. 13.
    Giannoccaro MP, Donadio V, Gomis Peres C (2011) Somatic and autonomic small fiber neuropathy induced by bortezomib therapy: an immunofluorescence study. Neurol Sci 32:361–363CrossRefGoogle Scholar
  14. 14.
    Stubgen JP (2008) Tumor necrosis factor-alfa antagonists and neuropathy. Muscle Nerve 37(3):281–292CrossRefGoogle Scholar
  15. 15.
    Adams D et al (2018) Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 379(1):11–21CrossRefGoogle Scholar
  16. 16.
    Levine TD (2018) Small fiber neuropathy: disease classification beyond pain and burning. J Cent Nerv Syst Dis 18(10):1179573518771703.  https://doi.org/10.1177/1179573518771703 eCollection 2018Google Scholar
  17. 17.
    Xiao Y, Barbosa C, Pei Z, Xie W, Strong JA, Zhang JM, Cummins TR (2019) Increased resurgent sodium currents in Nav1.8 contribute to nociceptive sensory neuron hyperexcitability associated with peripheral neuropathies. J Neurosci 39:1539–1550.  https://doi.org/10.1523/JNEUROSCI.0468-18.2018 CrossRefGoogle Scholar
  18. 18.
    Biegstraaten M, Hollak CEM, Bakkers M, Faber CG, Aerts JMFG, van Schaik IN (2012) Small fiber neuropathy in Fabry disease. Mol Genet Metab 106:135–141CrossRefGoogle Scholar
  19. 19.
    Hobson-Webb LD, Austin SL, Jain S (2015) Small-fiber neuropathy in Pompe disease: first reported cases and prospective screening of a clinic cohort. Am J Case Rep 16:196–201CrossRefGoogle Scholar
  20. 20.
    Cazzato D, Castori M, Lombardi F et al (2016) Small fiber neuropathy is a common feature of Ehlers-Danlos syndromes. Neurology 87(2):155–159CrossRefGoogle Scholar
  21. 21.
    Hovagiumian A, Gibbons CH (2011) Diagnosis and treatment of pain in small fiber neuropathy. Curr Pain Headache Rep 15(3):193–200CrossRefGoogle Scholar
  22. 22.
    Zouari HG, Wahab A, Ng Wing Tin S et al (2019) The clinical features of painful small-fibre neuropathy suggesting an origin linked to a primary Sjögren’s syndrome. Pain Pract.  https://doi.org/10.1111/papr.12763
  23. 23.
    Oaklander AL (2016) Immunotherapy prospects for painful small-fiber sensory neuropathies and ganglionopathies. Neurotherapeutics 13:108–117CrossRefGoogle Scholar
  24. 24.
    Magistris MR, Soichot P (2004) Neuropathy versus neuronopathy: distinguish features. Rev Med Liege 59(Suppl 1):208–218Google Scholar
  25. 25.
    Oaklander AL, Herzog ZD, Downs HM, Klein MM (2013) Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 154(11):2310–2316CrossRefGoogle Scholar
  26. 26.
    Tavee OJ, Stern BJ (2014) Neurosarcoidosis. Continuum (Minneap Minn) 20(3):545–559Google Scholar
  27. 27.
    Themistocleous AC, Ramirez JD, Serra J, Bennett DLH (2014) The clinical approach to small fiber neuropathy and painful channelopathy. Pract Neurol 14:368–379CrossRefGoogle Scholar
  28. 28.
    Sun B, Li Y, Liu L, Chen Z, Ling L, Yang F, Liu J, Liu H, Huang X (2018) SFN-SIQ, SFNSL, and skin biopsy of 55 cases with small fiber involvement. Int J Neurosci 128(5):442–448CrossRefGoogle Scholar
  29. 29.
    Wang L, Hilliges M, Jernberg T, Wiegleb-Edstrfm D, Johansson O (1990) Protein gene product 9.5-immunoreactive nerve fibers and cells in human skin. Cell Tissue Res 261:25–33CrossRefGoogle Scholar
  30. 30.
    Lawson VH, Grewal J, Hackshaw KV, Mongiovi PC, Stino AM (2018) Fibromyalgia syndrome and small fiber, early or mild sensory polyneuropathyю. Muscle Nerve 58(5):625–630CrossRefGoogle Scholar
  31. 31.
    Kennedy et al (1996) Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47(4):1042–1048CrossRefGoogle Scholar
  32. 32.
    Voortman M, Hendriks CMR, Elfferich P, Bonella F, Møller J, de Vries J, Costabel U, Drent M (2019) The burden of sarcoidosis symptoms from a patient perspective. Lung.  https://doi.org/10.1007/s00408-019-00206-7
  33. 33.
    Hoitsma E, de Vries J, Drent M (2010) The small fiber neuropathy screening list: construction and cross-validation in sarcoidosis. Respir Med 105:95–100CrossRefGoogle Scholar
  34. 34.
    Singleton RJ, Bixby B, Russel JW et al (2008) The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy. J Peripher Nerv Syst 13:218–227CrossRefGoogle Scholar
  35. 35.
    McCarthy BG, Hsieh ST, Stocks A et al (1995) Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 45:1848–1855CrossRefGoogle Scholar
  36. 36.
    Provitera V, Gibbons CH, Wendelschafer-Crabb G, Donadio V, Vitale DF, Stancanelli A, Caporaso G, Liguori R, Wang N, Santoro L, Kennedy WR, Nolano M (2016) A multi-center, multinational age- and gender-adjusted normative dataset for immunofluorescent intraepidermal nerve fiber density at the distal leg. Eur J Neurol 23:333–338CrossRefGoogle Scholar
  37. 37.
    Lauria G, Lombardi R, Camozzi F, Devigili G (2009) Skin biopsy for the diagnosis of peripheral neuropathy. Histopathology 54:273–285CrossRefGoogle Scholar
  38. 38.
    Bakkers M, Merkies ISJ, Lauria G, Devigili G, Penza P, Lombardi R, Hermans MCE, van Nes SI, de Baets M, Faber CG (2009) Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology 73:1142–1148CrossRefGoogle Scholar
  39. 39.
    Nolano M, Biasiotta A, Lombardi R, Provitera V, Stancanelli A, Caporaso G, Santoro L, Merkies ISJ, Truini A, Porretta-Serapiglia C, Cazzato D, Dacci P, Vitale DF, Lauria G (2015) Epidermal innervation morphometry by immunofluorescence and bright-field morphology. J Peripher Nerv Syst 20:387–391CrossRefGoogle Scholar
  40. 40.
    Sopacua M, Hoeijmakers JGJ, Merkies ISG et al (2018) Small fibre neuropathy: expanding the clinical pain universe. J Peripher Nerv Syst 24:19–33.  https://doi.org/10.1111/jns.12298 CrossRefGoogle Scholar
  41. 41.
    Provitera V, Nolano M, Caporaso G, Stancanelli A, Santoro L, Kennedy WR (2010) Evaluation of sudomotor function in diabetes using the dynamic sweat test. Neurology. 74(1):50–56CrossRefGoogle Scholar
  42. 42.
    McArthur JC (2012) Painful small fiber neuropathies. Continuum Lifelong Learning Neurol 18(1):106–125CrossRefGoogle Scholar
  43. 43.
    Lagerburg V, Bakkers M, Bouwhuis A, Hoeijmakers JGJ, Smit AM, van den Berg SJM, Hordijk-de Boer I, Brouwer-van der Lee MDG, Kranendonk D, Reulen JPH, Faber CG, Merkies ISJ (2015) Contact heat evoked potentials: normal values and use in small-fiber neuropathy. Muscle Nerve 51(5):743–749CrossRefGoogle Scholar
  44. 44.
    Atherton DD, Facer P, Roberts KM, Misra VP, Chizh BA, Bountra C, Anand P (2007) Use of the novel contact heat evoked potential stimulator (CHEPS) for the assessment of small fibre neuropathy: correlations with skin flare responses and intra-epidermal nerve fibre counts. BMC Neurol 7:21CrossRefGoogle Scholar
  45. 45.
    Hadjadj J, Dechartres A, Chapron T, Assala M, Salah S, Dunogué B, Musset L, Baudin B, Groh M, Blanche P, Mouthon L, Monnet D, le Jeunne C, Brézin A, Terrier B (2017) Relevance of diagnostic investigations in patients with uveitis: retrospective cohort study on 300 patients. Autoimmun Rev 16(5):504–511CrossRefGoogle Scholar
  46. 46.
    Grumet P, Kodjikian L, de Parisot A, Errera MH, Sedira N, Heron E, Pérard L, Cornut PL, Schneider C, Rivière S, Ollé P, Pugnet G, Cathébras P, Manoli P, Bodaghi B, Saadoun D, Baillif S, Tieulie N, Andre M, Chiambaretta F, Bonin N, Bielefeld P, Bron A, Mouriaux F, Bienvenu B, Vicente S, Bin S, Labetoulle M, Broussolle C, Jamilloux Y, Decullier E, Sève P, ULISSE group (2018) Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis: Clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis). Autoimmun Rev 17(4):331–343CrossRefGoogle Scholar
  47. 47.
    Delvigili G, Tugnoli V, Penza P et al (2008) The diagnostic criteria for small fibreneuropathy: from symptoms to neuropathology. Brain. 131:1912–1925CrossRefGoogle Scholar
  48. 48.
    Chiang M-C, Tseng M-T, Pan C-L, Chao CC, Hsieh ST (2015) Progress in the treatment of small fiber peripheral neuropathy. Expert Rev Neurother 15(3):305–313CrossRefGoogle Scholar
  49. 49.
    Tavee JO, Karwa K, Ahmed Z, Thompson N, Parambil J, Culver DA (2017) Sarcoidosis-associated small fiber neuropathy in a large cohort: clinical aspects and response to IVIG and anti-TNF alpha treatment. Respir Med 126:135–138CrossRefGoogle Scholar
  50. 50.
    Dabby R, Gilad R, Sadeh M et al (2006) Acute steroid responsive small-fiber neuropathy: a new entity? J Peripher Nerv Syst 11(1):47–52CrossRefGoogle Scholar
  51. 51.
    Wakasugi D, Kato T, Gono T (2009) Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjorgen syndrome. Mod Rheumatol 19:437–440CrossRefGoogle Scholar

Copyright information

© Fondazione Società Italiana di Neurologia 2019

Authors and Affiliations

  1. 1.Laboratory of the Mosaic of AutoimmunityFederal State Budget Educational Institution of Higher Education “St. Petersburg State University”Saint-PetersburgRussia
  2. 2.Department of Faculty TherapyFederal State Budget Educational Institution of Higher Education “St. Petersburg State University”Saint-PetersburgRussia
  3. 3.Ministry of Health of Russian FederationFederal State Budgetary Institution “St. Petersburg Research Institute of Phthisiopulmonology”St. PetersburgRussia
  4. 4.Department of Neurology, Talpiot Medical Leadership ProgramChaim Sheba Medical CenterTel Ha ShomerIsrael
  5. 5.Sackler Faculty of MedicineTel Aviv UniversityTel AvivIsrael
  6. 6.Zabludowicz Center for Autoimmune DiseasesChaim Sheba Medical CenterTel Ha ShomerIsrael

Personalised recommendations